Cargando…
Expansion of mouse castration-resistant intermediate prostate stem cells in vitro
BACKGROUND: Most castration-resistant prostate cancers (CRPCs) have a luminal phenotype with high androgen receptor (AR) and prostate-specific antigen (PSA) expression. Currently, it is difficult to culture castration-resistant luminal cells with AR and PSA expression. METHODS: We formulated a custo...
Autores principales: | Xu, Yalan, Mu, Jie, Zhou, Zhixia, Leng, Yu, Yu, Yali, Song, Xiuyue, Liu, Aihua, Zhu, Hai, Li, Jing, Wang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284701/ https://www.ncbi.nlm.nih.gov/pubmed/35841025 http://dx.doi.org/10.1186/s13287-022-02978-x |
Ejemplares similares
-
Correction: Expansion of mouse castration-resistant intermediate prostate stem cells in vitro
por: Xu, Yalan, et al.
Publicado: (2022) -
Expanding tubular microvessels on stiff substrates with endothelial cells and pericytes from the same adult tissue
por: Song, Xiuyue, et al.
Publicado: (2022) -
Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
por: Ozyigit, Gokhan, et al.
Publicado: (2019) -
Castration for Prostatic Hypertrophy
Publicado: (1899) -
Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)